search
Back to results

Use of an Osteoconductive Scaffold in ACL-Reconstruction (ACLROCS)

Primary Purpose

ACL - Anterior Cruciate Ligament Rupture, ACL, ACL Injury

Status
Active
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Osteoconductive scaffold-hamstring tendon composite repair
Hamstring tendon-only repair
Sponsored by
Sandro Fucentese
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for ACL - Anterior Cruciate Ligament Rupture focused on measuring ACL Reconstruction, Osteoconductive Scaffold, Bone Tunnel Widening

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion

  • Acute unilateral complete tear of the ACL that occurred within 18 weeks before planned surgery and requires reconstruction of the
  • Informed consent as documented by signature

Exclusion Criteria:

  • Prior ACL reconstruction or other surgical procedure on the affected knee.
  • Prior fracture of the affected leg.
  • Multi-ligament reconstruction.
  • Previous or current ACL injury on contra-lateral leg.
  • Medical condition or comorbidity that would interfere with study participation.
  • The patient is mentally compromised.
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
  • Other clinically significant concomitant disease states (e.g. renal failure, hepatic dysfunction, cardiovascular disease, etc.).

Sites / Locations

  • Balgrist University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control treatment

Experimental treatment

Arm Description

ACL-reconstruction using hamstring autograft with hybrid fixation in accordance with in-house standard of care.

ACL-reconstruction using hamstring autograft with hybrid fixation combined with the osteoconductive device under study.

Outcomes

Primary Outcome Measures

Bone tunnel volume
CT based relative change of the femoral bone tunnel volume from baseline to follow-up 1 and 2.

Secondary Outcome Measures

IKDC Subjective Knee Evaluation Form
International Knee Documentation Committee Subjective Knee Evaluation Form is designed to detect improvement or deterioration in symptoms, function and sports activities due to knee impairment for patients with a variety of knee conditions including ligament injuries. It is a patient-completed questionnaire available in multiple languages including German with an ordinal scoring system ranging from 0 (highest level of symptoms or lowest level of function) to 100 (no limitation with daily or sporting activities and the absence of symptoms).
Lysholm Knee Scoring Scale
To evaluate outcomes of knee ligament surgery, particularly symptoms of instability. It has an ordinal scoring system ranging from 0 to 100 (No symptoms or disability). A validated German version will be used.
Tegner Activity Scale
The Tegner activity scale (TAS) is used to measure the change in physical activity from pre-injury to follow-up. Patient's activity is scored on a scale with 11 levels from level 0 (on sick leave/disability) to level 10 (participation in competitive sports such as soccer at a national or international elite level). Evaluated will be the difference in score from pre-injury (assessed at baseline visit) to follow-up.
KT-1000 Arthrometer Test
The KT-1000 Arthrometer Test measures anterior displacement of the tibial plateau on the femur at a specific force. Its output variable is defined as the difference in full millimeters between the tibial displacement of the ACL reconstructed knee and the normal contralateral side.
Lachmann Test
The Lachman test measures anterior displacement conducted manually by the clinician. It is graded as the difference from the normal contralateral side as 0 (<3 mm), 1 (3 to 5 mm), or 2 (>5 mm).
Pivot shift test
The pivot shift test assesses the combined tibio-femoral rotation and anterior tibial translation. The pathologic motion elicited is graded as a glide (grade 1), clunk (grade 2), or gross clunk with locking (grade 3). A normal finding is graded as zero. The outcome measure is calculated from the difference between affected (repaired) and intact knee.
Bone tunnel width
Bone tunnel width will additionally be assessed on plain radiograph. Standard posteroanterior radiographs of the knee in full extension will be used. Bone tunnel width will be assessed at the widest part of the femoral bone tunnel. Assessed will be the relative change in femoral bone tunnel width.
Osteoconductive scaffold-bone integration
For a quantitative analysis of Osteoconductive scaffold (OCS)-bone integration, the mineral density profile along a predefined line will be examined. A slice showing the central portion of the OCS in the axial plane will be selected. A straight line of 2 cm length will be drawn perpendicular to the long axis of the OCS using image analysis software (Mimics). The CT-values along this line will be recorded and evaluated in the following way. Since the CT-values change according to the bone mineral density, the profile along the line will have a minimum at the interface of the tunnel wall and the OCS and a maximum on the OCS. The difference in Hounsfield units from the cancellous bone in the tunnel wall and the OCS-bone interface will be used as a measure for the degree of osseous integration of the implant.

Full Information

First Posted
December 29, 2017
Last Updated
July 24, 2020
Sponsor
Sandro Fucentese
search

1. Study Identification

Unique Protocol Identification Number
NCT03462823
Brief Title
Use of an Osteoconductive Scaffold in ACL-Reconstruction
Acronym
ACLROCS
Official Title
Randomized Controlled Trial for the Use of an Osteoconductive Scaffold in ACL-Reconstruction
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Active, not recruiting
Study Start Date
August 29, 2017 (Actual)
Primary Completion Date
June 29, 2021 (Anticipated)
Study Completion Date
April 29, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Sandro Fucentese

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Primary objective of the study is to evaluate efficacy of the surgical technique for ACL reconstruction using an osteoconductive scaffold, enlaced into the hamstring tendon autograft, compared to the traditional technique.
Detailed Description
Reconstruction of the anterior cruciate ligament (ACL) using autograft tissue is currently recommended as the standard of care following an ACL tear or rupture, with the bone-tendon-bone (BTB) graft and hamstring tendon graft the most common. Although a BTB autograft is widely recognized to offer high mechanical performance and rapid graft healing, these advantages come at the cost of a longer surgery time and higher risk of severe patient discomfort at the graft harvest site. Use of a hamstring tendon autograft is less painful, but is generally slower to heal with higher risk of mechanical graft failure due to poor bone ingrowth. The aim of the current study is to augment graft-to-bone incorporation by use of an osteoconductive scaffold enlaced into the hamstring tendon autograft. This bovine derived composite bone substitute is inserted into the articular aperture of the femoral bone tunnel and should provide an osteoconductive / osteoinductive environment at a biomimetic attachment site leading to improved secondary graft-fixation and a reduced incidence of tunnel widening. Primary objective of the study is to evaluate efficacy of the surgical technique for ACL reconstruction using an osteoconductive scaffold, enlaced into the hamstring tendon autograft, compared to the traditional technique. Secondary objectives aim to assess the clinical outcome of the interventional treatment including patient subjective knee function and objective measures of knee stability.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
ACL - Anterior Cruciate Ligament Rupture, ACL, ACL Injury
Keywords
ACL Reconstruction, Osteoconductive Scaffold, Bone Tunnel Widening

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized patient-blinded two-group parallel comparison trial using an active comparator.
Masking
Participant
Allocation
Randomized
Enrollment
56 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control treatment
Arm Type
Active Comparator
Arm Description
ACL-reconstruction using hamstring autograft with hybrid fixation in accordance with in-house standard of care.
Arm Title
Experimental treatment
Arm Type
Experimental
Arm Description
ACL-reconstruction using hamstring autograft with hybrid fixation combined with the osteoconductive device under study.
Intervention Type
Device
Intervention Name(s)
Osteoconductive scaffold-hamstring tendon composite repair
Intervention Description
The device under study is a composite bone substitute composed of a natural mineral matrix of bovine origin, reinforced with biodegradable synthetic polymers and natural collagen derivatives of bovine origin (smartbone, IBI S.A., Switzerland).
Intervention Type
Device
Intervention Name(s)
Hamstring tendon-only repair
Intervention Description
ACL-reconstruction using hamstring autograft with hybrid fixation in accordance with in-house standard of care.
Primary Outcome Measure Information:
Title
Bone tunnel volume
Description
CT based relative change of the femoral bone tunnel volume from baseline to follow-up 1 and 2.
Time Frame
0, 4.5, 12 months post surgery
Secondary Outcome Measure Information:
Title
IKDC Subjective Knee Evaluation Form
Description
International Knee Documentation Committee Subjective Knee Evaluation Form is designed to detect improvement or deterioration in symptoms, function and sports activities due to knee impairment for patients with a variety of knee conditions including ligament injuries. It is a patient-completed questionnaire available in multiple languages including German with an ordinal scoring system ranging from 0 (highest level of symptoms or lowest level of function) to 100 (no limitation with daily or sporting activities and the absence of symptoms).
Time Frame
0 and 42 days, 6 months, 1, 2 and 5 years post surgery
Title
Lysholm Knee Scoring Scale
Description
To evaluate outcomes of knee ligament surgery, particularly symptoms of instability. It has an ordinal scoring system ranging from 0 to 100 (No symptoms or disability). A validated German version will be used.
Time Frame
0 and 42 days, 6 months, 1, 2 and 5 years post surgery
Title
Tegner Activity Scale
Description
The Tegner activity scale (TAS) is used to measure the change in physical activity from pre-injury to follow-up. Patient's activity is scored on a scale with 11 levels from level 0 (on sick leave/disability) to level 10 (participation in competitive sports such as soccer at a national or international elite level). Evaluated will be the difference in score from pre-injury (assessed at baseline visit) to follow-up.
Time Frame
0 and 42 days, 6 months, 1, 2 and 5 years post surgery
Title
KT-1000 Arthrometer Test
Description
The KT-1000 Arthrometer Test measures anterior displacement of the tibial plateau on the femur at a specific force. Its output variable is defined as the difference in full millimeters between the tibial displacement of the ACL reconstructed knee and the normal contralateral side.
Time Frame
0 and 42 days, 6 months, 1, 2 and 5 years post surgery
Title
Lachmann Test
Description
The Lachman test measures anterior displacement conducted manually by the clinician. It is graded as the difference from the normal contralateral side as 0 (<3 mm), 1 (3 to 5 mm), or 2 (>5 mm).
Time Frame
0 and 42 days, 6 months, 1, 2 and 5 years post surgery
Title
Pivot shift test
Description
The pivot shift test assesses the combined tibio-femoral rotation and anterior tibial translation. The pathologic motion elicited is graded as a glide (grade 1), clunk (grade 2), or gross clunk with locking (grade 3). A normal finding is graded as zero. The outcome measure is calculated from the difference between affected (repaired) and intact knee.
Time Frame
0 and 42 days, 6 months, 1, 2 and 5 years post surgery
Title
Bone tunnel width
Description
Bone tunnel width will additionally be assessed on plain radiograph. Standard posteroanterior radiographs of the knee in full extension will be used. Bone tunnel width will be assessed at the widest part of the femoral bone tunnel. Assessed will be the relative change in femoral bone tunnel width.
Time Frame
0 and 42 days, 12 and 24 months post surgery
Title
Osteoconductive scaffold-bone integration
Description
For a quantitative analysis of Osteoconductive scaffold (OCS)-bone integration, the mineral density profile along a predefined line will be examined. A slice showing the central portion of the OCS in the axial plane will be selected. A straight line of 2 cm length will be drawn perpendicular to the long axis of the OCS using image analysis software (Mimics). The CT-values along this line will be recorded and evaluated in the following way. Since the CT-values change according to the bone mineral density, the profile along the line will have a minimum at the interface of the tunnel wall and the OCS and a maximum on the OCS. The difference in Hounsfield units from the cancellous bone in the tunnel wall and the OCS-bone interface will be used as a measure for the degree of osseous integration of the implant.
Time Frame
day 0, 4.5 and 12 months post surgery
Other Pre-specified Outcome Measures:
Title
Patient safety
Description
Any occurrence of intra-operative complications will be recorded on the case report forms. Post-operative (serious) adverse events will be recorded at each follow-up visit.
Time Frame
0 and 42 days, 6 months, 1, 2 and 5 years post surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Acute unilateral complete tear of the ACL that occurred within 18 weeks before planned surgery and requires reconstruction of the Informed consent as documented by signature Exclusion Criteria: Prior ACL reconstruction or other surgical procedure on the affected knee. Prior fracture of the affected leg. Multi-ligament reconstruction. Previous or current ACL injury on contra-lateral leg. Medical condition or comorbidity that would interfere with study participation. The patient is mentally compromised. Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant. Other clinically significant concomitant disease states (e.g. renal failure, hepatic dysfunction, cardiovascular disease, etc.).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sandro Fucentese
Organizational Affiliation
Head of Knee Surgery
Official's Role
Principal Investigator
Facility Information:
Facility Name
Balgrist University Hospital
City
Zürich
ZIP/Postal Code
8008
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Use of an Osteoconductive Scaffold in ACL-Reconstruction

We'll reach out to this number within 24 hrs